The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 5
- −1 vs. Q1 2021
- Portfolio value
- $706.5M
- −$337.2M (−32.3%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 15,396,116 | $303.6M | 43.0% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 3,885,679 | $123.5M | 17.5% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 3,347,245 | $106.2M | 15.0% | −233,007−6.5% | Reduced | History |
| CNSTConstellation Pharmaceuticals Inc | COM | 2,626,631 | $88.8M | 12.6% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 4,768,181 | $84.3M | 11.9% | 00.0% | Unchanged | History |
Sold out since Q1 2021 (1)
Positions held at the end of Q1 2021 that are gone from this filing.